Nebenwirkungen · Afstyla
AFSTYLA 250 IU powder and solvent for solution for injection AFSTYLA 500 IU powder and solvent for solution for injection AFSTYLA 1000 IU powder and solvent for solution for injection AFSTYLA 1500 IU powder and solvent for solution for injection AFSTYLA 2000 IU powder and solvent for solution for injection AFSTYLA 2500 IU powder and solvent for solution for injection AFSTYLA 3000 IU powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 7
HOS-134702 · Präparat HOS-097594
Summary of the safety profile Hypersensitivity or allergic reactions (which may include angioedema, burning and stinging at the injection site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed rarely with the use of factor VIII products and may in some cases progress to severe anaphylaxis (including shock).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-16T14:40:00Z · SHA-256 16ec7d420a0e09bb5f20f98483f709a76e364615274fa2d524545f907057147d · Passage 1796593dcb38a0fd7ca176bdc3120ab74ab99ee9a972bc6ab9b1583804ceabf7 · Zeichen 0–448 im Abschnitt